• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身 MRI 在多发性骨髓瘤中的应用:优化图像采集和阅读时间。

Whole body MRI in multiple myeloma: Optimising image acquisition and read times.

机构信息

Centre for Medical Imaging, Division of Medicine, University College London, London, United Kingdom.

Department of Radiology, University College Hospital, London, United Kingdom.

出版信息

PLoS One. 2020 Jan 30;15(1):e0228424. doi: 10.1371/journal.pone.0228424. eCollection 2020.

DOI:10.1371/journal.pone.0228424
PMID:31999774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6992198/
Abstract

OBJECTIVE

To identify the whole-body MRI (WB-MRI) image type(s) with the highest value for assessment of multiple myeloma, in order to optimise acquisition protocols and read times.

METHODS

Thirty patients with clinically-suspected MM underwent WB-MRI at 3 Tesla. Unenhanced Dixon images [fat-only (FO) and water-only (WO)], post contrast Dixon [fat-only plus contrast (FOC) and water-only plus contrast (WOC)] and diffusion weighted images (DWI) of the pelvis from all 30 patients were randomised and read by three experienced readers. For each image type, each reader identified and labelled all visible myeloma lesions. Each identified lesion was compared with a composite reference standard achieved by review of a complete imaging dataset by a further experienced consultant radiologist to determine truly positive lesions. Lesion count, true positives, sensitivity, and positive predictive value were determined. Time to read each scan set was recorded. Confidence for a diagnosis of myeloma was scored using a Likert scale. Conspicuity of focal lesions was assessed in terms of percent contrast and contrast to noise ratio (CNR).

RESULTS

Lesion count, true positives, sensitivity and confidence scores were significantly higher when compared to other image types for DWI (P<0.0001 to 0.003), followed by WOC (significant for sensitivity (P<0.0001 to 0.004), true positives (P = 0.003 to 0.049) and positive predictive value (P< 0.0001 to 0.006)). There was no statistically significant difference in these metrics between FO and FOC. Percent contrast was highest for WOC (P = 0.001 to 0.005) and contrast to noise ratio (CNR) was highest for DWI (P = 0.03 to 0.05). Reading times were fastest for DWI across all observers (P< 0.0001 to 0.014).

DISCUSSION

Observers detected more myeloma lesions on DWI images and WOC images when compared to other image types. We suggest that these image types should be read preferentially by radiologists to improve diagnostic accuracy and reporting efficiency.

摘要

目的

确定全身磁共振成像(WB-MRI)中最适合评估多发性骨髓瘤的图像类型,以优化采集方案和阅读时间。

方法

30 例临床疑似多发性骨髓瘤患者在 3T 磁共振仪上进行 WB-MRI 检查。对所有 30 例患者的未增强 Dixon 图像(仅脂肪[FO]和仅水[WO])、增强后 Dixon 图像(FO+对比剂和 WO+对比剂)和骨盆扩散加权图像(DWI)进行随机和三位有经验的读者阅读。对于每种图像类型,每位读者均识别并标记所有可见骨髓瘤病灶。将每个识别出的病灶与另一位经验丰富的顾问放射科医师对完整成像数据集的审查结果进行比较,以确定真正的阳性病灶。确定病灶计数、真正的阳性病灶、灵敏度和阳性预测值。记录每个扫描集的阅读时间。使用李克特量表对诊断骨髓瘤的信心进行评分。根据病灶对比度和对比噪声比(CNR)评估局灶性病灶的显影程度。

结果

与其他图像类型相比,DWI 的病灶计数、真正的阳性病灶、灵敏度和置信度评分显著更高(P<0.0001 至 0.003),其次是 WOC(灵敏度(P<0.0001 至 0.004)、真正的阳性病灶(P=0.003 至 0.049)和阳性预测值(P<0.0001 至 0.006)差异有统计学意义)。FO 和 FOC 之间在这些指标上没有统计学差异。WOC 的病灶对比度最高(P=0.001 至 0.005),DWI 的对比噪声比(CNR)最高(P=0.03 至 0.05)。所有观察者的 DWI 阅读时间最快(P<0.0001 至 0.014)。

讨论

与其他图像类型相比,观察者在 DWI 图像和 WOC 图像上检测到更多的骨髓瘤病灶。我们建议放射科医生优先阅读这些图像类型,以提高诊断准确性和报告效率。

相似文献

1
Whole body MRI in multiple myeloma: Optimising image acquisition and read times.全身 MRI 在多发性骨髓瘤中的应用:优化图像采集和阅读时间。
PLoS One. 2020 Jan 30;15(1):e0228424. doi: 10.1371/journal.pone.0228424. eCollection 2020.
2
Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study.全身狄克逊磁共振成像在多发性骨髓瘤中的诊断效用:一项多阅片者研究
PLoS One. 2017 Jul 3;12(7):e0180562. doi: 10.1371/journal.pone.0180562. eCollection 2017.
3
Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?全身 MRI 在肿瘤学中的应用:单个解剖 T2 Dixon 序列是否可以替代 T1 和 STIR 序列的组合来检测骨骼转移和骨髓瘤?
Eur Radiol. 2023 Jan;33(1):244-257. doi: 10.1007/s00330-022-09007-8. Epub 2022 Aug 4.
4
Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence.快速 Dixon 基多序列全身 MRI 对骨转移瘤的显示:序列的临床应用价值。
Magn Reson Imaging. 2013 Jun;31(5):669-75. doi: 10.1016/j.mri.2012.10.017. Epub 2013 Jan 3.
5
Comparison of Whole-Body DWI and F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma.全身弥散加权成像与 F-FDG PET/CT 检测多发性骨髓瘤髓内及髓外病变的比较。
AJR Am J Roentgenol. 2019 Sep;213(3):514-523. doi: 10.2214/AJR.18.20989. Epub 2019 Jun 5.
6
Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.全身 MRI 在多发性骨髓瘤治疗反应评估中的作用:临床反应与影像反应的比较。
Cancer Imaging. 2020 Jan 30;20(1):14. doi: 10.1186/s40644-020-0293-6.
7
The relative contrast ratio of malignant bone lesion is highest on relative Fat Fraction maps compared with T1-weighted and b900 DWI images.与T1加权图像和b900 DWI图像相比,恶性骨病变在相对脂肪分数图上的相对对比率最高。
Magn Reson Imaging. 2025 Apr;117:110331. doi: 10.1016/j.mri.2025.110331. Epub 2025 Jan 22.
8
Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.18F-FDG PET/CT 与全身扩散加权 MRI 在多发性骨髓瘤评估中的前瞻性比较。
Ann Hematol. 2020 Dec;99(12):2869-2880. doi: 10.1007/s00277-020-04265-2. Epub 2020 Sep 19.
9
Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.基于图谱的全脑扩散加权成像半自动分割定量多发性骨髓瘤肿瘤负荷。
Cancer Imaging. 2020 Jan 13;20(1):6. doi: 10.1186/s40644-020-0286-5.
10
Optimization of whole-body 2-[F]FDG-PET/MRI imaging protocol for the initial staging of patients with myeloma.用于骨髓瘤患者初始分期的全身2-[F]FDG-PET/MRI成像方案的优化
Eur Radiol. 2022 May;32(5):3085-3096. doi: 10.1007/s00330-021-08388-6. Epub 2021 Nov 29.

引用本文的文献

1
Influence of imaging method on fat fraction estimation for assessing bone marrow in metastatic prostate cancer.成像方法对评估转移性前列腺癌骨髓脂肪分数估计的影响。
Eur Radiol. 2025 Apr 11. doi: 10.1007/s00330-025-11564-7.
2
Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it.全身 MRI 在转移疾病和骨髓瘤中的现状与未来:如何以及为何您将使用它。
Skeletal Radiol. 2024 Sep;53(9):1815-1831. doi: 10.1007/s00256-024-04723-2. Epub 2024 Jul 15.
3
Test-retest, inter- and intra-rater reproducibility of size measurements of focal bone marrow lesions in MRI in patients with multiple myeloma.

本文引用的文献

1
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).骨髓瘤全身 MRI 采集、解读和报告指南:骨髓瘤反应评估和诊断系统(MY-RADS)。
Radiology. 2019 Apr;291(1):5-13. doi: 10.1148/radiol.2019181949. Epub 2019 Feb 26.
2
Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study.全身狄克逊磁共振成像在多发性骨髓瘤中的诊断效用:一项多阅片者研究
PLoS One. 2017 Jul 3;12(7):e0180562. doi: 10.1371/journal.pone.0180562. eCollection 2017.
3
Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
多发性骨髓瘤患者 MRI 中局灶性骨髓病变大小测量的重测信度、组内和组间信度。
Br J Radiol. 2023 Apr 1;96(1145):20220745. doi: 10.1259/bjr.20220745. Epub 2023 Apr 12.
4
Modern imaging techniques for monitoring patients with multiple myeloma.用于监测多发性骨髓瘤患者的现代成像技术。
Med Pharm Rep. 2022 Oct;95(4):377-384. doi: 10.15386/mpr-2215. Epub 2022 Oct 27.
5
Imaging for Plasma Cell Dyscrasias: What, When, and How?浆细胞异常增殖性疾病的影像学检查:检查什么、何时检查以及如何检查?
Front Oncol. 2022 Mar 24;12:825394. doi: 10.3389/fonc.2022.825394. eCollection 2022.
6
Myeloma Response Assessment and Diagnosis System (MY-RADS): strategies for practice implementation.骨髓瘤反应评估和诊断系统 (MY-RADS):实施策略。
Skeletal Radiol. 2022 Jan;51(1):11-15. doi: 10.1007/s00256-021-03755-2. Epub 2021 Mar 6.
7
Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.多发性骨髓瘤全身 MRI 成像图谱:重点在于弥散加权成像。
Br J Radiol. 2020 Nov 1;93(1115):20200312. doi: 10.1259/bjr.20200312. Epub 2020 Aug 26.
8
Clinical feasibility of ultrafast intracranial vessel imaging with non-Cartesian spiral 3D time-of-flight MR angiography at 1.5T: An intra-individual comparison study.1.5T 非笛卡尔螺旋 3D 时间飞跃磁共振血管成像超快颅内血管成像的临床可行性:一项个体内比较研究。
PLoS One. 2020 Apr 29;15(4):e0232372. doi: 10.1371/journal.pone.0232372. eCollection 2020.
全身磁共振成像、动态对比增强磁共振成像及扩散加权成像在多发性骨髓瘤分期中的应用
Skeletal Radiol. 2017 Jun;46(6):733-750. doi: 10.1007/s00256-017-2609-6. Epub 2017 Mar 13.
4
Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.高危细胞遗传学特征的多发性骨髓瘤的治疗:国际骨髓瘤工作组共识
Blood. 2016 Jun 16;127(24):2955-62. doi: 10.1182/blood-2016-01-631200. Epub 2016 Mar 21.
5
Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma.传统MRI、动态对比增强MRI和扩散加权成像联合评估用于多发性骨髓瘤患者的疗效评估
Eur J Radiol. 2016 Feb;85(2):373-82. doi: 10.1016/j.ejrad.2015.11.040. Epub 2015 Dec 2.
6
Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?全身扩散加权磁共振成像:评估多发性骨髓瘤患者疾病负担的新金标准?
Leukemia. 2016 Jun;30(6):1446-8. doi: 10.1038/leu.2015.338. Epub 2015 Dec 9.
7
Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalities.(18)F-FDG正电子发射断层显像(PET)与弥散加权成像(DWI)在多发性骨髓瘤中的应用:功能成像模式比较
Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):479-92. eCollection 2015.
8
Intravoxel Incoherent Motion Diffusion-weighted Imaging of Multiple Myeloma Lesions: Correlation with Whole-Body Dynamic Contrast Agent-enhanced MR Imaging.多骨髓瘤病灶的体素内不相干运动弥散加权成像:与全身动态对比剂增强磁共振成像的相关性。
Radiology. 2015 Dec;277(3):773-83. doi: 10.1148/radiol.2015141728. Epub 2015 Jul 1.
9
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.磁共振成像在多发性骨髓瘤患者管理中的作用:共识声明。
J Clin Oncol. 2015 Feb 20;33(6):657-64. doi: 10.1200/JCO.2014.57.9961. Epub 2015 Jan 20.
10
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.